What sector does Walpar Nutritions Limited belong to?

Walpar Nutritions Limited operates in the Healthcare sector, specifically the Pharmaceuticals industry, and is listed on the NSE.

What is the current share price of WALPAR?

As of the latest available quote, WALPAR traded at ₹115.10. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of WALPAR?

Walpar Nutritions Limited has a price-to-earnings (P/E) ratio of about 104.64. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of WALPAR?

The market capitalisation of Walpar Nutritions Limited is approximately ₹21 Cr.

Is Walpar Nutritions Limited profitable?

For its latest reported financial year, Walpar Nutritions Limited recorded a net profit margin of about 3.81%.

Does WALPAR pay a dividend?

Walpar Nutritions Limited does not currently show a dividend yield in our data.

What is the return on equity (ROE) of WALPAR?

Walpar Nutritions Limited has a return on equity (ROE) of about 13.90%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of WALPAR?

Over the past 52 weeks, WALPAR has traded between a low of ₹21.25 and a high of ₹50.60.

Walpar Nutritions Limited

WALPAR NSE Healthcare Pharmaceuticals

₹115.10

+4.97%

Delayed · cached 15 min

Fair value analysis

WALPAR

Walpar Nutritions Limited

₹23.00

Close used for this calculation

₹50.83Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

63/100

Profitability17/25

Returns18/25

Balance Sheet6/25

Efficiency22/25

Growth20/25

Good

Quality radar

Consensus fair value

₹50.83

Below FV

▲ +121.0% against the close used

Model range ₹35.02 – ₹158.81

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹35.02Fair value₹50.83Bull₹158.81

FairClose

52-week traded range

52W low ₹22.3552W high ₹46.65

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Walpar Nutritions Limited closed at ₹23.00, 54.8% below the consensus fair value of ₹50.83 drawn from 9 valuation models.

Financial DNA score 63/100 — Good. P/E of 8.5x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹52.20

+127.0%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=9%, r=10%, tg=3%, n=10yr

Graham Number

₹35.02

+52.2%

√(22.5 × EPS × BVPS)

EPS=2.63, BVPS=20.72

Graham Formula

₹118.44

+415.0%

EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate

g=20%, FD=7%

P/E Fair Value

₹93.89

+308.2%

EPS × 35.7x (sector P/E)

EPS=2.63, Sector P/E=35.7x

Peter Lynch (PEG)

₹65.75

+185.9%

EPS × Growth% (PEG = 1 is fair)

EPS=2.63, g=25%

EV/EBITDA

₹158.81

+590.5%

(EBITDA × 18x − Net Debt) ÷ Shares

EBITDA=90M

Book Value (P/B)

₹40.92

+77.9%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=20.72, ROE=13.9%, g=6%, r=10%

Reverse DCF

₹23.00

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: -4.2% | Historical: 25%

Margin of Safety

₹56.17

+144.2%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=74.89, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer